NHS to roll out two rapid diagnostic tests for endometriosis, potentially cutting years from diagnosis
The NHS will introduce two rapid diagnostic tests for endometriosis, aiming to cut the current 7–10 year diagnostic delay that…
Editor's Top Picks
Roche Discontinues Huntington’s Gene-Silencing Program Amid Competitive Pressures
Roche has discontinued its Huntington's disease gene-silencing program, highlighting competitive pressures in neurodegenerative therapeutics. The decision comes as ARPA-H launches…
Submit Your Paper to GMJ
A Father’s Fight: How One Family’s Quest Is Reshaping Rare Disease Drug Development
A father's advocacy for his daughter with ultra-rare NGLY1 deficiency is reshaping how experimental gene therapies reach patients when traditional…
Obesity as disease: Who profits from the classification shift?
Max Moser argues in STAT News that obesity's reclassification as a disease has accelerated pharmaceutical development while raising questions about…
Medical Cannabis in Older Adults: A Physician’s Case for Safe, Evidence-Based Prescribing
A physician with 25 years of experience treating medical cannabis patients argues that informed clinical prescribing—rather than categorical avoidance—offers the…
New drug slows lung decline in idiopathic pulmonary fibrosis, landmark trial shows
A new therapeutic approach shows the ability to slow lung function decline in idiopathic pulmonary fibrosis, according to analysis in…
Setmelanotide shows promise in treating acquired hypothalamic obesity, new trial demonstrates
A randomized controlled trial published in the New England Journal of Medicine demonstrates that setmelanotide, a melanocortin 4 receptor agonist,…
Intraoperative Brain Tumour Diagnosis: Innovation Without Infrastructure Is Theatre
A rapid intraoperative brain tumour test represents scientific progress, but healthcare systems lack the organizational infrastructure to deploy it equitably.…
A New Approach to Hypothalamic Obesity: Early Intervention and Weight Management Strategies
Acquired hypothalamic obesity, caused by damage to brain regions controlling hunger and metabolism, requires early identification and multidisciplinary treatment approaches.…
Cancer’s Hidden Cost: How Oncology Must Rethink Toxicity Monitoring
Modern cancer drugs extend survival, but oncology's toxicity monitoring systems—designed for acute effects during treatment—fail to detect and manage late-emerging…